The global diabetic macular edema market is on a steady growth trajectory, with an expected valuation of approximately USD 4,120.9 million in 2024. The market is poised to surpass USD 4,642.9 million by 2034, representing a modest compound annual growth rate (CAGR) of 1.2%. This growth underscores the increasing medical need as the global prevalence …
Tag Archives: Diabetic Macular Edema Market
Global Diabetic Macular Edema Market Projected to Reach USD 4,642.9 Million by 2034, Driven by Rising Diabetes Rates
The global diabetic macular edema market is projected to hold a valuation of approximately USD 4,120.9 million in 2024, with an anticipated growth trajectory that will see it surpass USD 4,642.9 million by 2034. This growth, although modest, reflects a compound annual growth rate (CAGR) of 1.2% through 2034, indicating a mature market landscape. As …
Global Diabetic Macular Edema Market Set for Steady Growth, Projected to Reach USD 4,642.9 Million by 2034
The global diabetic macular edema market is poised for steady expansion, with its value projected to increase from USD 4,120.9 million in 2024 to USD 4,642.9 million by 2034. This growth trajectory, marked by a modest Compound Annual Growth Rate (CAGR) of 1.20% over the next decade, highlights the rising demand for effective treatment solutions …
Global Diabetic Macular Edema Market Expected to Reach USD 4,642.9 Million by 2034
The global diabetic macular edema market is estimated to be valued at USD 4,120.9 million in 2024. Looking ahead, the market is projected to reach USD 4,642.9 million by 2034, reflecting a modest CAGR of 1.20% from 2024 to 2034. With diabetes being a leading cause of vision impairment and blindness, the rising incidence of …
Global Diabetic Macular Edema Market Poised for Steady Growth US$ 4.2 Billion by 2032: Despite Challenges, Driven by Rising Diabetes Rates | FMI
The global diabetic macular edema (DME) market is expected to reach a valuation of US$ 3.7 billion by the end of 2022, with a projected CAGR of 1.2% from 2022 to 2032, reaching a valuation of ~US$ 4.2 billion by the end of the forecast period, according to market research firm FMI. Despite a modest …
Global Diabetic Macular Edema Industry is predicted to achieve a US$ 4.2 Billion valuation by 2032
By the end of 2022, the global diabetic macular edema industry size is predicted to be valued US$ 3.7 billion. From 2022 to 2032, it is projected to grow at a compound annual growth rate (CAGR) of 1.2%. By the end of 2032, the market is expected to be valued at approximately US$ 4.2 billion. …
Global Diabetic Macular Edema Market is Projected to Witness Steady Growth a CAGR Of 1.2%, To Reach a Valuation of US$ 4.2 Billion By 2032
The global Diabetic Macular Edema Market Size is expected to reach a valuation of US$ 3.7 Billion by the end of 2022, and further expand at a CAGR of 1.2% from 2022 to 2032. The market is projected to reach a valuation of ~US$ 4.2 Billion by the end of 2032. Anti-VEGF drugs are the current standard of care for DME, and they …
Diabetic Macular Edema Market are set to witness a CAGR of 1.2% and be valued at around US$ 4.2 Billion by 2032
The global Diabetic Macular Edema Market Size is expected to reach a valuation of US$ 3.7 Billion by the end of 2022, and further expand at a CAGR of 1.2% from 2022 to 2032. The market is projected to reach a valuation of ~US$ 4.2 Billion by the end of 2032. An Uptake of Intravitreal Implants by Patients to Drive Growth of the …